Survivin: A potential prognostic marker and chemoradiotherapeutic target for colorectal cancer

Irish Journal of Medical Science

Volumn 179, Issue 3, 2010, Pages 327-335

  Xiaoyuan, C ^a   Longbang, C ^a   Jinghua, W ^a   Xiaoxiang, G ^a   Huaicheng, G ^a   Qun, Z ^a   Haizhu, S ^a  

^a NANJING GENERAL HOSPITAL OF NANJING MILITARY COMMAND   (China)

Author keywords

Chemoradiotherapy; Chemotherapy; Colorectal cancer; Inhibitors of apoptosis; Prognosis; Radiotherapy; RNA interference; Survivin

Indexed keywords

BIOCHEMICAL MARKER; COMPLEMENTARY DNA; FLUOROURACIL; MESSENGER RNA; SHORT HAIRPIN RNA; SURVIVIN;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL VIABILITY; CHEMOSENSITIVITY; COLORECTAL CANCER; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN EXPRESSION; RADIOSENSITIVITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; WESTERN BLOTTING;

ADULT; AGED; APOPTOSIS; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; DOWN-REGULATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM PROTEINS; PROGNOSIS; RADIOTHERAPY DOSAGE; RECTAL NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TUMOR STEM CELL ASSAY;

EID: 77955918894     PISSN: 00211265     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11845-009-0448-8     Document Type: Article

References (25)

1. A Jemal R Siegel E Ward, et al. 2008 Cancer statistics, 2008 CA Cancer J Clin 58 71 96 10.3322/CA.2007.0010 18287387 (Pubitemid 351521864)
2. BK Shelton 2002 Introduction to colorectal cancer Semin Oncol Nurs 18 2 12 10.1053/sonu.2002.33074 12053860
3. U Vanhoefer 2005 Molecular mechanisms and targeting of colorectal cancer Semin Oncol 32 7 10 10.1053/j.seminoncol.2005.07.018 16360005 (Pubitemid 41785431)
4. AD Schimmer 2004 Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice Cancer Res 64 7183 7190 10.1158/0008-5472.CAN- 04-1918 1:CAS:528:DC%2BD2cXosFyntr8%3D 15492230 (Pubitemid 39372048)
5. YL Yang XM Li 2000 The IAP family: endogenous caspase inhibitors with multiple biological activities Cell Res 10 169 177 10.1038/sj.cr.7290046 1:STN:280:DC%2BD3cvnvFGktw%3D%3D 11032169
6. AC Mita MM Mita ST Nawrocki, et al. 2008 Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics Clin Cancer Res 14 5000 5005 10.1158/1078-0432.CCR-08-0746 1:CAS:528:DC%2BD1cXpslKgsbs%3D 18698017
7. M Pennati M Folini N Zaffaroni 2008 Targeting survivin in cancer therapy Expert Opin Ther Targets 12 463 476 10.1517/14728222.12.4.463 1:CAS:528:DC%2BD1cXjtlGksrs%3D 18348682 (Pubitemid 351551639)
8. YG Wang KX Chen GL Wu, et al. 2005 An analysis: colon cancer mortality in Tianjin, China, from 1981 to 2000 World J Gastroenterol 11 895 898 15682489
9. A Carrato 2008 Adjuvant treatment of colorectal cancer Gastrointest Cancer Res 2 S42 S46 19343149
10. O Aranha AB Benson 3rd 2007 Adjuvant therapy for colon cancer Curr Gastroenterol Rep 9 415 421 10.1007/s11894-007-0052-x 17991344
11. Y Wei T Fan M Yu 2008 Inhibitor of apoptosis proteins and apoptosis Acta Biochim Biophys Sin 40 278 288 10.1111/j.1745-7270.2008.00407.x 18401525 (Pubitemid 351572108)
12. SM Srinivasula JD Ashwell 2008 IAPs: what's in a name? Mol Cell 30 123 135 10.1016/j.molcel.2008.03.008 1:CAS:528:DC%2BD1cXlsFentLY%3D 18439892 (Pubitemid 351626688)
13. S Fulda 2008 Targeting inhibitor of apoptosis proteins (IAPs) for cancer therapy Anticancer Agents Med Chem 8 533 539 1:CAS:528:DC%2BD1cXmvVarsro%3D 18537535
14. EC LaCasse DJ Mahoney HH Cheung, et al. 2008 IAP-targeted therapies for cancer Oncogene 27 6252 6275 10.1038/onc.2008.302 1:CAS:528:DC%2BD1cXht1GrtLrE 18931692
15. DC Altieri 2008 Survivin, cancer networks and pathway-directed drug discovery Nat Rev Cancer 8 61 70 10.1038/nrc2293 1:CAS:528:DC%2BD2sXhsVKku73M 18075512
16. J Sampath LM Pelus 2007 Alternative splice variants of survivin as potential targets in cancer Curr Drug Discov Technol 4 174 191 10.2174/157016307782109652 1:CAS:528:DC%2BD2sXhsVahtLfM 17986000 (Pubitemid 350171819)
17. EC Ulukus HA Kargi B Sis, et al. 2007 Survivin expression in non-small-cell lung carcinomas: correlation with apoptosis and other apoptosis-related proteins, clinicopathologic prognostic factors and prognosis Appl Immunohistochem Mol Morphol 15 31 37 10.1097/01.pai.0000201808.35931.78 1:CAS:528:DC%2BD2sXktlentrg%3D 17536304 (Pubitemid 46673313)
18. A Nassar D Sexton G Cotsonis, et al. 2008 Survivin expression in breast carcinoma: correlation with apoptosis and prognosis Appl Immunohistochem Mol Morphol 16 221 226 10.1097/PAI.0b013e3180c317bc 1:CAS:528:DC%2BD1cXnsVKrtL8%3D 18301249 (Pubitemid 351589545)
19. AI Sarela CS Verbeke J Ramsdale, et al. 2002 Expression of survivin, a novel inhibitor of apoptosis and cell cycle regulatory protein, in pancreatic adenocarcinoma Br J Cancer 86 886 892 10.1038/sj.bjc.6600133 1:CAS:528:DC%2BD38XjsVyqtrw%3D 11953819 (Pubitemid 34271023)
20. GY Chau AF Lee SH Tsay, et al. 2007 Clinicopathological significance of survivin expression in patients with hepatocellular carcinoma Histopathology 51 204 218 10.1111/j.1365-2559.2007.02738.x 17559540 (Pubitemid 47083982)
21. MR Hussein AK Haemel GS Wood 2003 Apoptosis and melanoma: molecular mechanisms J Pathol 199 275 288 10.1002/path.1300 1:CAS:528:DC%2BD3sXis1ektbY%3D 12579529 (Pubitemid 36266850)
22. S Ootsuka S Asami T Sasaki, et al. 2007 Analyses of novel prognostic factors in neuroblastoma patients Biol Pharm Bull 30 2294 2299 10.1248/bpb.30.2294 1:CAS:528:DC%2BD1cXht1ymtLk%3D 18057715 (Pubitemid 350225579)
23. A Troeger M Siepermann G Escherich, et al. 2007 Survivin and its prognostic significance in pediatric acute B-cell precursor lymphoblastic leukemia Haematologica 92 1043 1050 10.3324/haematol.10675 1:CAS:528: DC%2BD2sXhtFKrsrbK 17640858 (Pubitemid 350144210)
24. X Guo E Goessl G Jin, et al. 2008 Cell cycle perturbation and acquired 5-fluorouracil chemoresistance Anticancer Res 28 9 14 1:CAS:528: DC%2BD1cXjslWhsb8%3D 18383818
25. JT Leith LA Faulkner G Papa, et al. 1991 In vitro radiation survival parameters of human colon tumor cells Int J Radiat Oncol Biol Phys 20 203 206 1:STN:280:DyaK3M7itlWisQ%3D%3D 1991679